医药合约包装市场规模、份额及成长分析（按类型、材料及地区划分）－2026-2033年产业预测

全球药品合约包装市场规模预计在 2024 年达到 70.6 亿美元，从 2025 年的 75.9 亿美元增长到 2033 年的 135.5 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.51%。

全球医药合约包装市场正经历显着成长，主要受对高品质化学品包装需求不断增长的推动，尤其是在新兴市场。製药公司越来越多地转向合约包装服务以降低生产成本，而这一转变正在推动市场扩张。中小型製药公司面临着许多挑战，例如缺乏内部包装资源、专业知识和资金限制，因此与合约包装组织 (CPO) 合作成为一种极具吸引力的解决方案。这种合作不仅可以缓解资源短缺，还能透过经济高效的服务交付提高效率。製药业的整体成长进一步推动了这一趋势，越来越多的公司选择外包其包装需求，因为外包可以带来许多优势，例如获得先进技术、提高营运效率和获得更优质的服务。

全球医药合约包装市场驱动因素

全球医药合约包装市场的成长主要得益于製药企业外包趋势的日益增长。面对复杂的包装要求、严格的监管标准以及成本效益的需求，许多公司开始寻求专业包装公司的协助。这种转变使製药企业能够专注于药物研发和行销等核心业务，同时充分利用合约包装商的专业知识。这些专家提供创新且合规的包装解决方案，帮助製药公司提高营运效率，并专注于将高品质产品推向市场。

全球医药合约包装市场的限制因素

全球医药合约包装市场面临着监管合规的诸多挑战。各国包装和标籤法规的多样性及其不断变化，为该行业的企业带来了许多限制。企业必须遵守特定的指导方针，包括关于密封性和耐久性保证的规定。对于缺乏必要资源的中小型合约包装企业而言，维持这些繁多标准的合规性所带来的财务负担尤其沉重。此外，违规的潜在后果，例如产品召回和法律诉讼，进一步加剧了企业在该市场有效运作的困难。

全球医药合约包装市场趋势

全球医药合约包装市场正经历着向永续包装解决方案的重大转变，这主要受到消费者和监管机构日益增长的减少环境影响的压力所推动。业内相关人员正增加对创新材料的投资，以满足减少包装体积的需求，同时优先考虑可生物降解性和可回收性。这一趋势反映了更广泛的永续性倡议，合约包装公司积极参与研发，以开发符合监管要求的环保产品。因此，市场正在不断发展，永续性考量已成为包装策略和商业实践的核心要素，以满足日益增长的环保解决方案需求。

目录

介绍

• 调查目标
• 市场定义和范围

调查方法

• 调查过程
• 二手资料和一手资料方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争格局概述

市场动态与展望

• 总体经济指标
• 驱动因素和机会
• 限制与挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 影响市场的因素
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 技术评估

全球医药合约包装市场规模（按类型及复合年增长率划分）（2026-2033 年）

• 初级包装
• 二级包装
• 三级包装

全球医药合约包装市场规模（依材料及复合年增长率划分）（2026-2033 年）

• 塑胶和聚合物
• 纸和纸板
• 玻璃
• 铝箔
• 其他的

全球医药合约包装市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Amcor plc
• Newell Brands
• Nipro Corporation
• Daito Pharmaceutical Co., Ltd.
• Pfizer
• West Pharmaceutical Services, Inc.
• Smurfit Westrock
• Thermo Fisher Scientific Inc.（Patheon）
• Novo Holdings（Catalent, Inc.）
• Simtra BioPharma Solutions
• Kohlberg & Company LLC（PCI Pharma Services）
• Vetter Pharma International GmbH
• The McClay Foundation（Almac Group）
• CordenPharma International
• Aphena Pharma Solutions
• Ecobliss Packaging Group
• Recipharm AB
• Ropack Inc.
• Korber AG

结论与建议

Global Pharmaceutical Contract Packaging Market size was valued at USD 7.06 Billion in 2024 and is poised to grow from USD 7.59 Billion in 2025 to USD 13.55 Billion by 2033, growing at a CAGR of 7.51% during the forecast period (2026-2033).

The global pharmaceutical contract packaging market is witnessing significant growth driven by rising demand for high-quality chemical packaging, particularly from emerging markets. Pharmaceutical companies are increasingly opting for contract packaging services to minimize manufacturing costs, a shift that enhances market expansion. Small pharmaceutical enterprises face challenges such as limited in-house packaging resources, expertise, and financial constraints, making partnerships with contract packaging organizations (CPOs) an attractive solution. This collaboration not only addresses their resource limitations but also fosters efficiency through cost-effective service delivery. The overall growth of the pharmaceutical sector further propels this trend, as outsourcing packaging offers benefits like advanced technology, streamlined operations, and superior service delivery, resulting in an upsurge in companies outsourcing their packaging needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Contract Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Contract Packaging Market Segments Analysis

Global Pharmaceutical Contract Packaging Market is segmented by Type, Material, and region. Based on Type , the market is segmented into Primary Packaging (Bottles, Vials, Ampoules, Blister Packs, Others), Secondary Packaging, Tertiary Packaging. Based on Material, the market is segmented into Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Contract Packaging Market

The growth of the Global Pharmaceutical Contract Packaging market is significantly driven by the increasing trend of outsourcing among pharmaceutical companies. As these companies encounter complex packaging requirements, strict regulatory standards, and the need for cost efficiency, many are turning to specialized packaging firms. This shift allows pharmaceutical producers to concentrate on their core activities, such as drug development and marketing, while benefiting from the expertise of contract packaging providers. These specialists offer innovative and compliant packaging solutions, enabling pharmaceutical companies to enhance their operational efficiency and focus on delivering high-quality products to the market.

Restraints in the Global Pharmaceutical Contract Packaging Market

The global pharmaceutical contract packaging market faces significant challenges due to the complexities of regulatory compliance. The diverse and constantly evolving packaging and labeling regulations across various countries create a restrictive environment for businesses operating in this sector. Companies must adhere to specific guidelines, including those related to indestructible seals and durability assurances. The financial burden of maintaining compliance with these extensive standards can be particularly daunting for small to medium-sized contract packaging firms, which often lack the necessary resources. Additionally, the potential consequences of non-compliance, such as product recalls or legal actions, further complicate their ability to operate effectively in this market.

Market Trends of the Global Pharmaceutical Contract Packaging Market

The Global Pharmaceutical Contract Packaging market is witnessing a significant shift towards sustainable packaging solutions, driven by escalating consumer and regulatory pressures to minimize environmental impact. Industry players are increasingly investing in innovative materials that prioritize biodegradability and recyclability, while also addressing the need to reduce packaging volume. This trend reflects a broader commitment to sustainability, with contract packaging companies actively engaging in research and development to create environmentally friendly products that comply with regulatory requirements. As a result, the market is evolving, with sustainability considerations becoming a central pillar in packaging strategies, aligning business practices with the growing demand for eco-conscious solutions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Pharmaceutical Contract Packaging Market Size by Type & CAGR (2026-2033)

• Market Overview
• Primary Packaging
• Secondary Packaging
• Tertiary Packaging

Global Pharmaceutical Contract Packaging Market Size by Material & CAGR (2026-2033)

• Market Overview
• Plastics & Polymers
• Paper & Paperboard
• Glass
• Aluminum Foil
• Others

Global Pharmaceutical Contract Packaging Market Size & CAGR (2026-2033)

• North America (Type, Material)
  • US
  • Canada
• Europe (Type, Material)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Material)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Material)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Material)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Amcor plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Newell Brands
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daito Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smurfit Westrock
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. ( Patheon)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Holdings (Catalent, Inc.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Simtra BioPharma Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kohlberg & Company LLC (PCI Pharma Services)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter Pharma International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The McClay Foundation (Almac Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CordenPharma International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aphena Pharma Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ecobliss Packaging Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recipharm AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ropack Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Korber AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations